Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for shortening mycoplasma clinical detection time under A-PEG-B array

A technology of A-PEG-B and mycoplasma, which is applied in the detection of microbiological mycoplasma, ureaplasma urealyticum and mycoplasma hominis, can solve problems such as harm, and achieve the effect of speeding up time and speeding up infection

Inactive Publication Date: 2010-10-06
其昌达生物高科技(上海)有限公司
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the research on mycoplasma in China has only been recorded for more than ten years, it has been proved that mycoplasma infection exists widely in the mainland, and it has great influence and harm on human beings

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] The present invention dissolves polyethylene glycol having a (OCH2CH2O)n--repetitive structure, that is, PEG, into Ureaplasma protolyticum (Uu) & Mycoplasma hominis (Mh) for cultivation, identification, quantification, and drug sensitivity In the in vitro diagnostic kits, the clinic is compounded with the A-PEG-B array. Among them, A: Uu (Ureaplasma urealyticum) & Mh (Mycoplasma hominis) detected in the patient's body; PEG: In this reaction complex, it carries the dual functions of active targeting and passive targeting;

[0017] Among them, B: is a biological medium with high activity.

[0018] The working principle of the present invention is: in the complex reaction at the right end of the A-PEG-B array, under the action of polyethylene glycol, the complementary and slow-release effects of all active substances can be highlighted; the antibacterial ability and biological activity of the culture medium , significantly lasting and improving. In the complex reaction a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for shortening mycoplasma clinical detection time under an A-PEG-B array, which belongs to the technical field of biology. The method comprises the following steps of: dissolving polyethylene glycol (PEG) having a repeated structure of --(OH2CH2O)n-- into an in-vitro diagnostic kit for culturing, identifying, quantifying and medicinally sensitizing ureaplasmaurealyticum (Uu) and mycoplasma hominis (Mh) to promote clinical recombination with the A-PEG-B array. In the method, in recombination reaction at the right end of the A-PEG-B array, the functions of the PEG in the complementation and controlled-release of all active substances are highlighted; in the recombination reaction at the left end of the A-PEG-B array, the osmotic pressure function of the PEG is highlighted; at the right end of the A-PEG-B array, the antibiotic capacity and biological activity of a culture medium are simultaneously improved; and at the left end of the A-PEG-B array, the detected Uu and Mh are repaired to different extents and the activity of the detected Uu and Mh on the culture medium is improved. Compared with the prior art, the method has the advantages of obtaining detection results 12 to 24 earlier and remarkably shortening time for curing sicknesses to save patients.

Description

technical field [0001] The present invention relates to the field of biological detection, in particular to a method for detecting mycoplasma in microbiology, in particular to a method for detecting Ureaplasma urealyticum and Mycoplasma hominis, specifically a method under the A-PEG-B array, significantly A detection method that speeds up the time to clinical diagnosis and treatment of Mycoplasma. Background technique [0002] Mycoplasma is a subject that has gradually developed in the past 30 years. It is an internationally recognized pathogen that causes urinary tract infections. It involves clinical tests. Department of infertility, eugenics, cancer and AIDS, etc. Although China's research on mycoplasma has only been recorded for more than ten years, it has been proved that mycoplasma infection exists widely in the mainland, and it has great influence and harm on human beings. In July 2008, at the 17th World Mycoplasma Conference, scientists from all over the world expr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/04
Inventor 倪今颖
Owner 其昌达生物高科技(上海)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com